Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options. - Wikidata - awgldk - TriplyDB

Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.

Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.

http://www.wikidata.org/entity/Q33417613

about

Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.Eculizumab in Transplant-Associated Thrombotic Microangiopathy.Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.Post-bone marrow transplant thrombotic microangiopathy.New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?Use of defibrotide to treat transplant-associated thrombotic microangiopathy: a retrospective study of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation.Terminal Complement Blockade after Hematopoietic Stem Cell Transplantation Is Safe without Meningococcal Vaccination.Defibrotide Successful Treatment of Transplant Associated Thrombotic Microangiopathy (TA-TMA) with Low Dose Defibrotide

P2860

Q28069228-236C1C5D-CA31-4F6C-BC9B-BACA9B13E44E Q30276550-09B3DDC9-801A-4B20-8C35-091B0C828A40 Q33424902-6A9895D6-D090-42A0-9976-B4E712EBC51D Q33425079-D81716DE-F003-4139-A9D6-319166C80AB7 Q33426602-236A1CE7-1912-49AF-A500-3FDB97F81ABE Q33428744-217D781F-E305-49BB-B578-A38599E5FDB8 Q33430697-148A7CF8-D84D-4608-9A6F-43AC288CB123 Q33432069-3A22EB6E-26FD-4DF5-8B56-A66B5B7D9584 Q38806679-20FD3278-6BDB-4CFE-AF04-B59BC9EAA31E Q39018396-91A1C6ED-1478-4671-B88E-983C89CAAA35 Q40722182-2A0673FF-C057-495C-BCB7-750328C7FE4C Q42793744-90C63050-DC91-4A39-A44B-69B7FBBE4721 Q56529806-C1852005-E9C8-4C48-8E59-BD10FF5747A1

P2860

Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.

http://www.wikidata.org/entity/Q33417613

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Hematopoietic stem cell transp ...... armacologic treatment options.

@ast

Hematopoietic stem cell transp ...... armacologic treatment options.

@en

type

label

Hematopoietic stem cell transp ...... armacologic treatment options.

@ast

Hematopoietic stem cell transp ...... armacologic treatment options.

@en

prefLabel

Hematopoietic stem cell transp ...... armacologic treatment options.

@ast

Hematopoietic stem cell transp ...... armacologic treatment options.

@en

P1433

Q33417613-3A886DD7-DE5E-4BD4-A5E7-F27E4AF74723

P1476

Q33417613-DCE5ACA7-2400-4F31-B78E-84356F0D0EC9

P2093

Q33417613-043E943F-21FE-4746-B1F2-90A9780CF749

Q33417613-50891C39-E082-4070-BA47-11CC854FA88D

Q33417613-AF274802-87B6-4B8C-81E7-0C65989AA9B9

Q33417613-E00ED206-9B84-435A-B5FA-C044D3D7FA56

P2860

Q33417613-05FFB825-E5BF-454F-BFBA-A4487E2931B3

Q33417613-2119378B-1969-42A8-9E48-ABA1CFDB989C

Q33417613-2C1F5FF0-B359-4C13-9FCF-849B9B523981

Q33417613-3AC31E15-0CF9-44CC-BB78-A7869C94CECD

Q33417613-43C7E7A2-5CE5-48A5-913D-8E48E4833703

Q33417613-4E074F02-798F-48C6-83DB-9F76564DFCAA

Q33417613-4E39B162-066F-45DE-8B53-FB7A25F76469

Q33417613-4E8372C6-A151-4DF9-93CB-A35F6751A0EC

Q33417613-628CBBD1-37BF-41A8-AFB4-772FDBFCB1FE

Q33417613-7945BE6C-0575-488C-B40B-278F4954690B

P304

Q33417613-A6A7E3C4-DFA3-42D4-8B76-57ADF646FEE2

P31

Q33417613-3A6498DA-09CE-4C63-A328-0B9B910E75C0

Q33417613-6f1ce99c-124c-4dfe-80aa-9dfb3f1e3762

P356

Q33417613-2AC11D79-6F45-4419-8D84-5BEBADCA2510

P433

Q33417613-DEA979D6-A5F4-4FE2-8EB8-853EEB78B975

P478

Q33417613-9F8C6923-AFEF-46ED-9B1D-D67E316497C3

P577

Q33417613-07A93401-7B16-436A-A142-4C57205B80E3

P698

Q33417613-FB0E6BAA-C07F-4B91-A204-B1AE3071803E

P356

P1433

P1476

Hematopoietic stem cell transp ...... armacologic treatment options.

@en

P2093

Alla Keyzner

http://www.w3.org/2001/XMLSchema#string

Kendra Yum

http://www.w3.org/2001/XMLSchema#string

Monank Patel

http://www.w3.org/2001/XMLSchema#string

Sara S Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases.

Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation.

Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver.

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma.

Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion.

Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation.

Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants.

Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group.

Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment.

Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation.

P304

452-458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRF.12859

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25209960

http://www.w3.org/2001/XMLSchema#string